Your Global Validated System Is Burning Money — Because You Have No Demand Management

Introduction: When “Go-Live” Is Just the Beginning

Many pharma leaders still treat the go-live of a validated global system (LIMS, EM, QMS, ERP, MES, etc.) as the finish line. The system is validated, rolled out to multiple sites, and users have access to a ticketing tool for “enhancements” and issues. On paper, the project is a success.

What happens in reality:

• Each site starts submitting its own enhancement tickets. The ticket system silently mutates into the de facto global demand tool. No one is systematically aligning requests across sites. No one is packaging them into controlled releases. No one is making sure decisions are traceable, fair, and compliant.
• The result is a slow-motion money burn: redundant work, frustrated sites, political battles, and a growing risk that your validated state is more fiction than fact.
• This article looks at why this happens, how regulators will look at it, and what a robust demand and release management setup should look like for validated global systems in large organizations (3+ sites).

1. The Hidden Problem: Tickets Are Not Demand Management

Most global deployment programs give the business users a ticketing tool for incidents and enhancements. That is fine for break/fix. For strategic change control and demand, it is a trap.

Typical pattern in large organizations:

• After global go-live, each site can raise enhancement tickets directly to the global system team.
• There is no formal global demand process, no structured portfolio, and no accountable demand manager.
• The ticket tool becomes the “truth” for demand: if it’s in Jira/ServiceNow, it exists; if not, it doesn’t.

This creates several structural issues:

• Sites have zero visibility: They cannot see which demands other sites have raised, whether similar issues exist, or if a topic is already being evaluated.
• Redundant problem solving: Different sites spend time, energy, and money to describe and “sell” the same issue at different points in time.
• Island solutions: The global team implements ad hoc, site-specific enhancements without any harmonized view of global business needs.
• Overloaded product owner: One product owner or tech owner is forced into a quasi-political decision-maker role without a clear mandate or governance.

From a GMP perspective, this is more than an efficiency problem. Each uncontrolled or poorly justified change chips away at your documented validated state and the traceability regulators expect under EU GMP Annex 11 and comparable FDA expectations for computerized systems.Public Health+1

2. How This Plays Out in Real Life: Frustration, Politics, and CAPAs

Here are typical symptoms we see in large, global companies:

2.1. Multiple sites rediscover the same pain

Example:

• Site A struggles with the batch disposition workflow in your global LIMS. They raise a ticket explaining their pain, propose an enhancement, and have several workshops with the global team.
• Three months later, Site C reports the same core issue from a slightly different angle and goes through another full round of scoping and justification.
• In parallel, Site B has created a local workaround process in Excel, which is now quietly used for months.

Three sites, three different efforts, one underlying problem. Nobody connects the dots because there is no single demand manager scanning and clustering these topics.

2.2. Perceived “random” rejections

Because the product owner or technical lead has no structured decision process, they often reject tickets informally: too complex, not needed, “we don’t have capacity,” or “this is a local problem.”

What the sites see:

• They invest time to document a need.
• They get a short rejection with no clear rationale.
• They are not told if similar topics were raised by other sites, or if their issue might be solved as part of a different change package later.

This fuels:

• Complaints in the background (“Global does not care about us”).
• Loss of trust in the global team and in the system itself.
• Growing political friction between global and local leadership.

2.3. Intransparent prioritization

In reality, some sites and products are more business-critical than others. That is fine. The problem starts when this fact is handled informally and not communicated in a professional way.

If Site X keeps getting their demands accepted and implemented quickly, while Site Y waits for months with no explanation, the story at Site Y becomes: “Global only supports the favorite site.”

2.4. Regulatory consequences

During inspections, regulators often focus on:

• Change control traceability for validated systems.
• Decision rationales for why certain changes were implemented or rejected.
• Evidence that changes were risk assessed for all impacted regions (e.g., EU vs. US expectations for batch release and documentation).U.S. Food and Drug Administration+1

Typical findings and CAPAs in this area:

• No holistic overview of changes across the global system.
• No documented rationale for rejecting business-critical enhancement requests.
• Local workarounds not reflected in the global validation documentation.
• Inconsistent implementation of regulatory requirements across sites.

These issues end up as CAPAs that require building exactly what was missing from the start: a structured, risk-based demand and release management concept.

3. Quick Self-Diagnostic: Do You Actually Have Demand and Release Management?

Use this checklist as a quick reality check. If you answer “No” or “Not sure” to several statements, your global validated system is probably running without a real demand process.

Check all that apply:

• You can generate a single, consolidated list of global change demands for your validated system, clustered by topic and site.
• Every demand has a documented decision (accept / reject / park) and a short, business readable rationale.
• Sites can see, at least at summary level, which demands are under evaluation and which are already decided.
• There is a clear, documented RACI showing who decides on demands for each process domain (e.g., stability, lot disposition, EM trending).
• Regulatory impacts (EU vs. US vs. other regions) are systematically considered for critical demands.
• Release packages are planned proactively (e.g., quarterly or semi-annual) and communicated to sites in advance.
• Each release is accompanied by structured release notes that explain: what changes, why it changes, and which original demand triggered it.
• Local sites can plan their local change control activities based on timely release information, without constant ad hoc calls to the global team.

If you struggled with several of these points, your system is likely governed by tickets, not by a demand and release strategy.

4. What “Good” Looks Like: Demand Management for Validated Global Systems

4.1. A named, skilled demand manager

A functioning model always has a dedicated demand manager or demand lead, not just “the product owner on top of everything else.” This person:

• Monitors the global demand backlog and clusters tickets into themes.
• Identifies duplicates and similar demands across sites early.
• Prepares structured decision packages for the governance body (not just raw tickets).
• Communicates decisions and next steps back to sites in a transparent, business-appropriate way.

Soft skills are as important as technical skills here. The demand manager must be able to:

• Bring together several conflicting viewpoints (5–7 different stakeholders, sometimes more).
• Distinguish what needs to be communicated to sites and what should remain internal.
• Translate management priorities into respectful, understandable messages to sites (“Your demand is planned for Q4” instead of “You’re less important”).

4.2. Governance anchored in global process ownership

Decisions about process-related enhancements must not sit with a single IT or tech person. For example:

• Stability workflow changes: Stability global process owner + system business owner + system technical lead decide together.
• Lot disposition or batch release changes: Global QA, regulatory, and supply chain representation must be involved to reflect EMA and FDA expectations for release decisions and documentation.Public Health+1

This governance should be documented clearly in a RACI/RACI-style matrix and referenced in your quality system (e.g., global SOP on computerized system lifecycle management, aligned with GAMP 5 2nd Edition).ISPE+1

4.3. From tickets to demand packages

Instead of implementing one ticket at a time, the demand manager groups similar or related items into demand packages, such as:

• “Global batch disposition improvements”
• “Stability workflow harmonization”
• “Environmental monitoring trending enhancements”

Each package is evaluated with:

• Global business impact across sites.
• Regulatory impact (which regions, which regulations).
• Technical feasibility and validation impact.

Only then do you decide which packages go into the next releases.

4.4. Structured release management

A controlled release concept for validated systems should include:

• Release planning: defined cadence (e.g., quarterly), with room for urgent fixes.
• Release notes: shared with all impacted sites ahead of go-live, including:

• Summary of changes.
• Original demand reference(s).
• High-level process impact.
• Required actions for sites (e.g., local SOP updates, training).

Validation documentation: change control, impact assessment, updated testing as required by your risk-based validation approach (aligned with GAMP 5 2nd Edition and Annex 11 expectations).ISPE+1

Handled correctly, releases become a communication tool and a compliance tool at the same time. Sites know what is coming; inspectors see a clear narrative from demand to change control to release.

5. Compliance Clarity: How FDA and EMA Will View This

From a regulator’s perspective, the core expectations are not “Do you have a demand manager?” but:

• Is your validated state maintained over the lifecycle of the system?
• Are changes controlled, justified, and documented?
• Are data integrity and patient safety protected when the system evolves?

Key references that support a structured demand and release concept:

• EU GMP Annex 11 — requires validated applications, qualified infrastructure, and appropriate change control and documentation over the lifecycle of computerized systems.Public Health+1
• FDA “Data Integrity and Compliance With Drug CGMP: Questions and Answers” — emphasizes traceability, justification, and control of changes affecting CGMP data.U.S. Food and Drug Administration+1
• ISPE GAMP 5 2nd Edition — promotes a lifecycle and risk-based approach for GxP computerized systems, highlighting critical thinking and structured governance to keep systems fit for intended use.ISPE+1

Inspectors are increasingly sensitive to:

• Uncontrolled local workarounds because global changes are “too hard” to get through.
• Inconsistent functionality or controls across sites using the “same” validated system.
• Long, undocumented backlogs of enhancement requests with no clear rationale for decisions.

A well-defined demand and release process allows you to show that:

• Business needs are collected and assessed systematically.
• Changes are prioritized based on risk and business criticality, not politics.
• Decisions and rationales are documented, traceable, and communicated.

6. Action: How to Fix Your Global Demand and Release Management

Here is a practical path leaders can take:

Step 1: Acknowledge that tickets are not enough

Make it explicit at steering committee level: “We need a structured demand and release model for our validated systems.” Without that decision, everything else becomes a side project.

Step 2: Map your current reality

Ask your global team:

• Where is the current backlog? (Tickets, spreadsheets, SharePoint lists)
• How many demands are duplicates or near-duplicates across sites?
• Which decisions were made by a single person without formal governance?
• How often are release notes sent to sites, and what is their quality?

Step 3: Define governance and roles

Create or update a global SOP that describes:

• Demand management process (from ticket to decision).
• Governance bodies and their composition (per process domain).
• RACI for major decision types (stability, batch release, EM, etc.).
• Interfaces between global and local change control.

Step 4: Appoint a demand manager

Choose a person with strong communication and structuring skills. Give them:

• Clear mandate from senior management.
• Access to the full demand backlog.
• Authority to question, cluster, and reframe tickets before they reach governance.

Step 5: Introduce release packages and release notes

Agree a practical release cadence and start with light but consistent release notes that include:

• Scope of the release.
• Links to original demand items.
• Expected process impact.
• Required local actions and recommended timelines.

Step 6: Integrate with your validation framework

Align the new process with your validation strategy:

• Update your computerized system lifecycle SOP to reference demand and release management.
• Align testing and documentation effort with the risk of the change, as promoted by GAMP 5 2nd Edition and current CSA thinking.ISPE+1

Step 7: Communicate, communicate, communicate

Finally, explain the new concept to your sites:

• What they can expect.
• How their demands will be treated.
• How and when they will receive information about upcoming releases.

Once sites feel heard and informed, the political noise reduces, and the quality of demands improves.

7. Leadership and Strategy: Turning Demand Chaos Into Strategic Advantage

Good demand and release management is not just “more governance.” It is a strategic lever. For leaders, a robust process delivers three advantages:

• Better investment decisions: A transparent, clustered view of global demands shows where your money actually needs to go.
• Faster, cleaner rollouts: When demands are harmonized and prioritized, each new site onboarding benefits from the lessons learned elsewhere; you avoid rebuilding the same solution again and again.
• Stronger compliance posture: A controlled, documented lifecycle for your global systems supports inspections, reduces CAPAs, and protects your license to operate.

In many companies, the cost of bad demand management does not appear in any single budget line. It hides in lost time, unnecessary meetings, rework, and local workarounds. Senior leaders who bring structure into this area quickly see both qualitative and financial benefits.

A simple rule of thumb: if your global validated system is already in operation across several sites and you cannot show, within a few minutes, how global demand is governed and how releases are decided and communicated, you have a strategic gap. Closing that gap is one of the most effective ways to protect both compliance and business value.

If you like, next step could be to tailor this article to a specific system type (e.g., LIMS/EM, QMS, MES) or to weave in anonymized case stories from your Takeda or other project experience to make it even more concrete.